These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 31262330)
1. Mucin 17 inhibits the progression of human gastric cancer by limiting inflammatory responses through a MYH9-p53-RhoA regulatory feedback loop. Yang B; Wu A; Hu Y; Tao C; Wang JM; Lu Y; Xing R J Exp Clin Cancer Res; 2019 Jul; 38(1):283. PubMed ID: 31262330 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic downregulation of MUC17 by H. pylori infection facilitates NF-κB-mediated expression of CEACAM1-3S in human gastric cancer. Lin S; Zhang Y; Hu Y; Yang B; Cui J; Huang J; Wang JM; Xing R; Lu Y Gastric Cancer; 2019 Sep; 22(5):941-954. PubMed ID: 30778796 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer. Ge F; Wang C; Wang W; Liu W; Wu B Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284 [TBL] [Abstract][Full Text] [Related]
4. Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis. Luu Y; Junker W; Rachagani S; Das S; Batra SK; Heinrikson RL; Shekels LL; Ho SB Int J Biochem Cell Biol; 2010 Jun; 42(6):996-1006. PubMed ID: 20211273 [TBL] [Abstract][Full Text] [Related]
5. Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer. Mori Y; Kataoka H; Miura Y; Kawaguchi M; Kubota E; Ogasawara N; Oshima T; Tanida S; Sasaki M; Ohara H; Mizoshita T; Tatematsu M; Asai K; Joh T Int J Cancer; 2007 Jul; 121(2):241-7. PubMed ID: 17330845 [TBL] [Abstract][Full Text] [Related]
6. Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer. Chang HR; Nam S; Lee J; Kim JH; Jung HR; Park HS; Park S; Ahn YZ; Huh I; Balch C; Ku JL; Powis G; Park T; Jeong JH; Kim YH Oncotarget; 2016 Dec; 7(49):81435-81451. PubMed ID: 27806312 [TBL] [Abstract][Full Text] [Related]
7. CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer. Wang S; Wu X; Zhang J; Chen Y; Xu J; Xia X; He S; Qiang F; Li A; Shu Y; Røe OD; Li G; Zhou JW Gut; 2013 Apr; 62(4):496-508. PubMed ID: 22535373 [TBL] [Abstract][Full Text] [Related]
8. Induction of Pro-Inflammatory Response via Activated Macrophage-Mediated NF-κB and STAT3 Pathways in Gastric Cancer Cells. Zhou Y; Xia L; Liu Q; Wang H; Lin J; Oyang L; Chen X; Luo X; Tan S; Tian Y; Su M; Wang Y; Chen P; Wu Y; Wang H; Liao Q Cell Physiol Biochem; 2018; 47(4):1399-1410. PubMed ID: 29929193 [TBL] [Abstract][Full Text] [Related]
9. MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA. Chen Z; Liu S; Xia Y; Wu K Med Sci Monit; 2016 Dec; 22():4679-4691. PubMed ID: 27904131 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of HOXA10 in gastric cancer with the intestinal mucin phenotype: reduction during tumor progression and favorable prognosis. Sentani K; Oue N; Naito Y; Sakamoto N; Anami K; Oo HZ; Uraoka N; Aoyagi K; Sasaki H; Yasui W Carcinogenesis; 2012 May; 33(5):1081-8. PubMed ID: 22411957 [TBL] [Abstract][Full Text] [Related]
11. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway. Zeng B; Shi W; Tan G BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764 [TBL] [Abstract][Full Text] [Related]
12. Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4. Ding L; Zhao Y; Dang S; Wang Y; Li X; Yu X; Li Z; Wei J; Liu M; Li G Mol Cancer; 2019 Mar; 18(1):45. PubMed ID: 30922402 [TBL] [Abstract][Full Text] [Related]
13. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5. Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189 [TBL] [Abstract][Full Text] [Related]
14. Gastrin regulates the TFF2 promoter through gastrin-responsive cis-acting elements and multiple signaling pathways. Tu S; Chi AL; Lim S; Cui G; Dubeykovskaya Z; Ai W; Fleming JV; Takaishi S; Wang TC Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1726-37. PubMed ID: 17332476 [TBL] [Abstract][Full Text] [Related]
15. The C-terminus of the transmembrane mucin MUC17 binds to the scaffold protein PDZK1 that stably localizes it to the enterocyte apical membrane in the small intestine. Malmberg EK; Pelaseyed T; Petersson AC; Seidler UE; De Jonge H; Riordan JR; Hansson GC Biochem J; 2008 Mar; 410(2):283-9. PubMed ID: 17990980 [TBL] [Abstract][Full Text] [Related]
16. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways. Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880 [TBL] [Abstract][Full Text] [Related]
17. MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis. Li S; Liang X; Ma L; Shen L; Li T; Zheng L; Sun A; Shang W; Chen C; Zhao W; Jia J Oncogene; 2018 Feb; 37(7):884-896. PubMed ID: 29059152 [TBL] [Abstract][Full Text] [Related]
18. The human transmembrane mucin MUC17 responds to TNFα by increased presentation at the plasma membrane. Schneider H; Berger E; Dolan B; Martinez-Abad B; Arike L; Pelaseyed T; Hansson GC Biochem J; 2019 Aug; 476(16):2281-2295. PubMed ID: 31387973 [TBL] [Abstract][Full Text] [Related]
19. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway. Lin MT; Lin BR; Chang CC; Chu CY; Su HJ; Chen ST; Jeng YM; Kuo ML Int J Cancer; 2007 Jun; 120(12):2600-8. PubMed ID: 17304514 [TBL] [Abstract][Full Text] [Related]
20. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer. Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]